AKR1C1 Antikörper (AA 1-110)
Kurzübersicht für AKR1C1 Antikörper (AA 1-110) (ABIN560581)
Target
Alle AKR1C1 (DDH) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 1-110
- 
                                            Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant AKR1C1.
- 
                                            Sequenz
- MDSKYQCVKL NDGHFMPVLG FGTYAPAEVP KSKALEATKL AIEAGFRHID SAHLYNNEEQ VGLAIRSKIA DGSVKREDIF YTSKLWCNSH RPELVRPALE RSLKNLQLDY
- 
                                            Kreuzreaktivität
- Human
- 
                                            Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- 
                                            Immunogen
- AKR1C1 (AAH20216, 1 a.a. ~ 110 a.a) partial recombinant protein with GST tag.
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 50 % glycerol
- 
                                            Handhabung
- Aliquot to avoid repeated freezing and thawing.
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
- 
                                            
- 
    - 
                                            : "Cisplatin resistance in human cervical, ovarian and lung cancer cells."    in: Cancer chemotherapy and pharmacology, Vol. 75, Issue 6, pp. 1217-27, (2015)         (PubMed).        
 : "Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells." in: Oncogene, Vol. 27, Issue 13, pp. 1916-29, (2008) (PubMed).
 
 
- 
                                            : "Cisplatin resistance in human cervical, ovarian and lung cancer cells."    in: Cancer chemotherapy and pharmacology, Vol. 75, Issue 6, pp. 1217-27, (2015)         (PubMed).        
- 
    - AKR1C1 (DDH) (Dihydrodiol Dehydrogenase (DDH))
- 
                                            Andere Bezeichnung
- AKR1C1
- 
                                            Hintergrund
- 
                        Full Gene Name: aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1, 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
 Synonyms: 2-ALPHA-HSD,20-ALPHA-HSD,C9,DD1,DDH,DDH1,H-37,HAKRC,MBAB,MGC8954
- 
                                            Gen-ID
- 1645
- 
                                            Pathways
- Steroid Hormone Biosynthesis, C21-Steroid Hormone Metabolic Process
 Target
- 
                    
 
                                     
                                     
                                    